Literature DB >> 23808828

Synergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell line.

Rongrong Zhu1, Xianzheng Wu, Yu Xiao, Bo Gao, Qian Xie, Hui Liu, Shilong Wang.   

Abstract

Curcumin and 5-Fluorouracil (5-Fu) have been reported to have anticancer potentials and show certain synergetic effect on some cancer cell lines. However, the poor bioavailability and rapid metabolism limited their medical application. In this study, we encapsulated curcumin with solid lipid nanoparticles (SLN), 5-Fu with Layered double hydroxides (LDHs) separately and tested its properties and anticancer potentials. SLN-curcumin and LDH-5-Fu were determined to be 100 and 60 nm by Transmission Electron Microscopy detection, and the loading efficiency were 28%±2.5% and 16.7%±1.8%, individually. Furthermore, SLN-curcumin and LDH-5-Fu showed a significantly synergetic effect on SMMC-7721 cell stronger than plain drugs together, of which the Idrug loaded nano-carriers was only 0.315. FACS analysis revealed that the combination of SLN-curcumin and LDH-5-Fu induced 80.1% apoptosis in SMMC-7721 cells, which were 1.7-folds of the sum of the two plain drug loaded carriers. The results demonstrated the significant synergetic anticancer potentials of nano-encapsulated curcumin and 5-Fu, which could be further explored for the treatment of other carcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23808828      PMCID: PMC3777555          DOI: 10.1089/cbr.2012.1445

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  40 in total

1.  Interaction index and different methods for determining drug interaction in combination therapy.

Authors:  J J Lee; M Kong; G D Ayers; R Lotan
Journal:  J Biopharm Stat       Date:  2007       Impact factor: 1.051

Review 2.  Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity.

Authors:  Soo-Jin Choi; Jin-Ho Choy
Journal:  Nanomedicine (Lond)       Date:  2011-07       Impact factor: 5.307

3.  Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition.

Authors:  Hyunsung Choi; Yang-Sook Chun; Seung-Won Kim; Myung-Suk Kim; Jong-Wan Park
Journal:  Mol Pharmacol       Date:  2006-07-31       Impact factor: 4.436

Review 4.  Defects of the apoptotic pathway as therapeutic target against cancer.

Authors:  Tetsuo Mashima; Takashi Tsuruo
Journal:  Drug Resist Updat       Date:  2005-12-09       Impact factor: 18.500

5.  Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF.

Authors:  Mareike Ströfer; Wolfgang Jelkmann; Reinhard Depping
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

6.  Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model.

Authors:  Min-Ah Choi; Seong Hwan Kim; Won-Yoon Chung; Jae-Kwan Hwang; Kwang-Kyun Park
Journal:  Biochem Biophys Res Commun       Date:  2005-01-07       Impact factor: 3.575

Review 7.  Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs.

Authors:  Jonathan B Baell; David C S Huang
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

8.  Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles.

Authors:  R R Zhu; L L Qin; M Wang; S M Wu; S L Wang; R Zhang; Z X Liu; X Y Sun; S D Yao
Journal:  Nanotechnology       Date:  2009-01-12       Impact factor: 3.874

9.  Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma.

Authors:  Youwei Li; Zhengguang Chen; Fei Li; Jichen Wang; Zongming Zhang
Journal:  Int J Nanomedicine       Date:  2012-08-22

10.  Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer.

Authors:  M Gusella; A C Frigo; C Bolzonella; R Marinelli; C Barile; A Bononi; G Crepaldi; D Menon; L Stievano; S Toso; F Pasini; E Ferrazzi; R Padrini
Journal:  Br J Cancer       Date:  2009-04-21       Impact factor: 7.640

View more
  4 in total

Review 1.  Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals.

Authors:  Chuan Li; Jia Zhang; Yu-Jiao Zu; Shu-Fang Nie; Jun Cao; Qian Wang; Shao-Ping Nie; Ze-Yuan Deng; Ming-Yong Xie; Shu Wang
Journal:  Chin J Nat Med       Date:  2015-09

2.  Synergistic Effects of Curcumin and 5-Fluorouracil on the Hepatocellular Carcinoma In vivo and vitro through regulating the expression of COX-2 and NF-κB.

Authors:  Ting Xu; Pu Guo; Chao Pi; Yingmeng He; Hongru Yang; Yi Hou; Xianhu Feng; Qingsheng Jiang; Yumeng Wei; Ling Zhao
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

3.  Effective inhibition of colon cancer cell growth with MgAl-layered double hydroxide (LDH) loaded 5-FU and PI3K/mTOR dual inhibitor BEZ-235 through apoptotic pathways.

Authors:  Jiezhong Chen; Renfu Shao; Li Li; Zhi Ping Xu; Wenyi Gu
Journal:  Int J Nanomedicine       Date:  2014-07-16

4.  Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression.

Authors:  Xiaolie He; Yanjing Zhu; Mei Wang; Guoxin Jing; Rongrong Zhu; Shilong Wang
Journal:  Int J Nanomedicine       Date:  2016-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.